Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Findlay › NPI 1962501627
Physician

Blanchard Valley Medical Practice LLC

Blanchard Valley Medical Practice LLC was paid $9.69M by Medicaid between Jan 2018 and Dec 2024, across 92 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 44% of everything it billed.

33Billing provider infoBLANCHARD VALLEY MEDICAL PRACTICE LLC
FINDLAY, OH 45840
33aNPI1962501627assigned 09/21/2006
28Total paid$9.69M
24GClaims309,351
24DCodes billed92
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Pulmonary Disease Physician providers in Ohio

Rank by total paid#1 of 42
Median peer was paid$34K
This provider vs. median282×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201844,969$1.46M
201946,251$1.48M
202041,926$1.23M
202142,469$1.33M
202243,017$1.33M
202354,417$1.65M
2024incomplete36,302$1.21M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 44% 110,353 98,510 $4.25M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 26% 46,824 43,363 $2.55M
90460 Immunization administration through 18 years of age via any route, first or only component 5.3% 27,619 15,576 $514K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 5.1% 9,129 8,563 $495K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 3.9% 7,760 7,256 $374K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 2.8% 5,106 4,804 $270K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1.4% 4,067 3,651 $132K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 1.3% 4,383 3,892 $122K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 1.2% 1,953 1,854 $115K
92558 <1% 8,514 7,923 $87K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 3,758 3,191 $82K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,214 1,036 $71K
80 more codes
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 3,282 $53K
99203 Doctor's office visit, new patient (routine) <1% 1,019 $49K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 3,966 $45K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 792 $35K
90832 Psychotherapy session, about 30 minutes <1% 935 $35K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 3,704 $34K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 741 $32K
96127 <1% 6,342 $29K
99309 Subsequent nursing facility care, per day, low to moderate complexity <1% 3,302 $27K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 381 $23K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 393 $23K
59025 Fetal non-stress test <1% 814 $21K
99308 Subsequent nursing facility care, per day, straightforward <1% 2,921 $20K
36415 Collection of venous blood by venipuncture <1% 8,658 $20K
92587 <1% 904 $16K
99215 Doctor's office visit, returning patient (complex) <1% 264 $16K
99381 <1% 237 $14K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,069 $13K
90834 Psychotherapy session, about 45 minutes <1% 255 $13K
D1208 Topical application of fluoride, excluding varnish <1% 979 $11K
92552 <1% 836 $9K
90686 <1% 4,370 $7K
59409 Vaginal delivery only (with or without episiotomy and/or forceps) <1% 12 $7K
90670 <1% 4,734 $7K
76801 <1% 103 $7K
99173 <1% 2,171 $5K
99442 <1% 230 $5K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 347 $4K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 53 $4K
99283 Emergency room visit (moderate) <1% 126 $4K
83036 Hemoglobin; glycosylated (A1C) <1% 854 $4K
99284 Emergency room visit (serious) <1% 67 $3K
87807 <1% 302 $3K
90633 <1% 2,243 $2K
90710 <1% 1,889 $2K
90474 <1% 268 $2K
76830 Ultrasound, transvaginal <1% 25 $2K
87210 <1% 357 $1K
90671 <1% 757 $1K
99307 <1% 204 $1K
99177 <1% 249 $962.13
81025 <1% 196 $957.98
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 13 $901.69
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 15 $864.72
H1000 Prenatal care, at-risk assessment <1% 12 $852.61
99306 Prolong nursin fac eval 15m <1% 55 $837.83
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 77 $813.38
90723 <1% 4,075 $582.97
97802 <1% 12 $575.62
90647 <1% 3,808 $526.51
90473 <1% 38 $445.09
99441 <1% 34 $382.88
81002 <1% 205 $366.02
99188 <1% 37 $348.60
90677 <1% 310 $299.72
90734 <1% 437 $284.81
0124A <1% 12 $279.57
90656 <1% 226 $277.70
90681 <1% 1,698 $159.86
81003 <1% 120 $126.91
90651 <1% 338 $70.12
G0008 Administration of influenza virus vaccine <1% 14 $27.95
90715 <1% 86 $20.37
90672 <1% 146 $20.33
82962 <1% 13 $18.66
90700 <1% 332 $10.81
90696 <1% 121 $10.67
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) <1% 85 $3.18
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 32 $1.24
91307 <1% 44 $0.27
90685 <1% 78 $0.03
91312 <1% 12 $0.03
3074F <1% 1,871 $0.02
3078F <1% 1,514 $0.02
3079F 0% 635 $0.00
3075F 0% 213 $0.00
3080F 0% 121 $0.00
0503F 0% 284 $0.00
3077F 0% 184 $0.00
90461 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCYTLAK, DAVID (VP)
Same official

Other billing entities under CYTLAK, DAVID

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.